Since plasmin activation occurs in vivo at sites of injury (i.e., on vascular and arterial walls or vascular basement membrane), an intersection between TTR amyloid formation and the fibrinolytic system corresponds to previous observations concerning CAVD [155]. The gene discussed is TTR; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.